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Abstract  
AIM: To determine whether cigarette smoking, as a risk factor for CAD, affects (anti)oxidant status. 
MATERIAL AND METHODS: The study included patients with CAD, divided according to their 
smoking status and the number of cigarettes smoked during a day. Biological markers of oxidative 
stress (concentration of oxidants and activity of antioxidant enzymes) were measured in all 
subjects. 
RESULTS: The study included 300 patients with CAD, (average age of 63 ± 11 years), 
predominantly males. Of the total, 34.0% were active smokers, 23.0% were former smokers, and 
43.0% were non-smokers. Most of the active smokers smoked 1-20 cigarettes/day. In terms of 
concentration of oxidants (MDA and HP) there was not a significant difference between smokers 
versus non-smokers. As for the activity of antioxidant enzymes (SOD, CAT and GPX), a statistically 
significant difference was found in the activity of GPX among the active smokers with CAD and the 
non-smokers with CAD (p = 0.039).  
CONCLUSION: Smoking as a risk factor for CAD is closely associated with increased oxidative 
stress, and the number of cigarettes smoked plays an important role in increasing the level of 
oxidative damage and reducing antioxidant defence.
 
 
 
 
 
 
 
 
 
Introduction 
 
Smoking and cigarette smoke are among the 
dominant risk factors for premature or accelerated 
development of peripheral, coronary and cerebral 
atherosclerotic vascular disease. Cigarette smoke 
contains more than 4000 identified ingredients [1] 
including nicotine, ammonia, acrolein, phenols, 
acetaldehyde, polycyclic aromatic hydrocarbons, 
polyphenols, then carbon monoxide, nitrogen oxides, 
hydrogen cyanide, trace metals [2, 3]. 
Two main phases have been identified in 
cigarette smoke, tar phase and gas phase. The two 
phases are rich free radicals, and non-radical 
oxidants. Superoxide radical (.O2-), and particularly 
hydroxyl radical (.OH), and peroxyl (.ROO) are able to 
initiate oxidative damage in the form of lipid 
peroxidation [4]. 
Because oxidative modification dominates the 
current concept of the pathogenesis of 
atherosclerosis, many studies, including that of 
Marangon et al. [5], have been focused on oxidative 
stress as potentially clinically relevant factor where 
cigarette smoke is associated with cancer and 
atherogenesis. They considered that smokers have a 
triple threat, first as they actively smoke cigarettes, 
second because of unhealthy nutrition with reduced 
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intake of antioxidants and finally because of 
consumption of large amounts of alcohol during 
smoking [6]. As a result, they increased oxidative 
stress and reduced antioxidant protection. 
It is believed that smoking causes increased 
oxidative stress because of several mechanisms, 
including direct damage by radical species and the 
inflammatory response caused by cigarette smoking 
[7].  
Peroxyl radicals and reactive nitrogen species 
cause direct damage stimulating lipid peroxidation and 
oxidation of proteins and DNA bases; aldehydes can 
deplete GSH (reduced glutathione) and modify protein 
-SH and -NH2 groups; cigarette smoke tar phase 
hydroquinone/quinine complexes diffuse across cell 
membranes, give rise to semiquinones and lead to the 
formation of superoxide radicals and hydrogen 
peroxide (H2O2) [8]. 
The damage caused by ROS (reactive 
oxygen species) in cigarette smoking occurs as an 
imbalance between production and detoxification of 
these species. Defence against oxidative stress is 
provided by a system of enzymes and antioxidants 
capable of preventing excess production of ROS and 
neutralizing free radicals [9].  
Antioxidant enzymes such as superoxide 
dismutase (SOD), catalase (CAT) and glutathione 
peroxidase (GPX) are an important line of defence 
against oxidative cell damage preventing lipid 
peroxidation, and protein and DNA oxidation. 
The aim of this study was to determine 
whether cigarette smoking as a risk factor for coronary 
artery disease (CAD), affects (anti)oxidant status, and 
induces oxidative stress. For this purpose, we 
compared the biological markers of (anti)oxidant 
status (concentration of oxidants and antioxidant 
enzymes activity) in patients with CAD divided 
according to their smoking status, and the number of 
cigarettes smoked in active smokers. 
 
 
Materials and Methods 
 
The study included 300 patients with CAD, 
admitted to the University Clinic of Cardiology in 
Skopje. 
Patients were examined for risk factors for 
CAD, with particular reference to smoking as a risk 
factor. Patients were divided into appropriate 
subgroups. According to their smoking status, the 
patients were separated into non-smokers, active 
smokers and former smokers. Non-smokers were 
those who during their life had never started smoking. 
Active smokers were those who smoked daily, over 
several years. According to the number of cigarettes 
smoked in 24 hours, active smokers were divided into: 
patients who smoked 1-20 cigarettes/per day, patients 
who smoked 21-40 cigarettes/per day and > 40 
cigarettes/per day. Former smokers were those who 
during their life had actively smoked, but due to 
various influences stopped smoking. 
The following parameters were determined in 
all patients: erythrocyte concentration of thiobarbituric 
acid reactive substances (TBARS), expressed as 
malondialdehyde (MDA), concentration of total 
hydroperoxides (HP) in plasma, both products of lipid 
peroxidation, and also the activity of erythrocyte 
antioxidant enzymes: superoxide dismutase (SOD), 
catalase (CAT) and glutathione peroxidase (GPX). 
Fasting blood samples were collected by 
venepuncture of all participants, in tubes that 
contained EDTA as an anticoagulant. The blood was 
centrifuged at 4000 g for 10 minutes at 4ºC, 
immediately after venepuncture.  
Plasma and leukocytes layer were separated, 
and the erythrocytes were washed three times with 
two volumes of saline. Then, a known volume of 
washed red cells were lysed with ice-cold distilled 
water (1:4), were left for 15 minutes in a refrigerator at 
a temperature of 4ºC, and cell debris was removed by 
centrifugation (10 minutes at 2000 g at a temperature 
of 4ºC). Samples of plasma and red cell lysates were 
kept at a temperature of -70ºC until the analysis. 
 
 
Results  
 
Basal characteristics of the study 
population 
In our study we have included 300 patients 
with coronary artery disease. Within the total number 
of subjects, 187 (62.3%) patients were diagnosed with 
acute coronary artery disease and 113 (37.7%) 
patients with chronic (ischemic) coronary heart 
disease. 
Patients had an average age of 63 ± 11 
years, and were predominantly male (194 or 64.67% 
men and 106 women or 35.33%). 
 
Risk Factors for CAD 
Risk factors for CAD that were present in 
patients are shown in Fig. 1. All patients were divided 
according to their smoking status: 102 (34%) active 
smokers, 69 (23%) former smokers and 129 (43%) 
non-smokers. The group of 102 (34%) active smokers 
was divided into subgroups according to the number 
of cigarettes they smoked per day and night, which is 
shown in Fig. 1. 
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Figure 1: Risk factors for CAD (top) and active smokers by number 
of cigarettes smoked per day (bottom) 
 
 
Biological markers of oxidative stress and 
smoking 
We measured concentration of malondial-
dehyde (MDA) and the concentration of total 
hydroperoxides (HP) in patients with CAD, divided 
according to their smoking status. The results are 
presented on Table 1.
 
Table 1: Concentration of MDA and total HP (respectively) in 
patients with CAD, depending on smoking status 
  Pts Min Max Mean Standard deviation 
MDA (nmol/ml) | former smokers 69 20.153 65.915 33.791 7.605 
MDA (nmol/ml) | non-smokers
 129 17.260 81.857 33.474 8.178 
MDA (nmol/ml) | active smokers 102 20.908 108.508 35.187 10.943 
(ANOVA, p = 0.344) (Kruskal-Wallis ANOVA, p = 0.313).
 
Total HP (CARR U) | former smokers 69 126.000 530.542 283.770 70.042 
Total HP (CARR U) | non-smokers
 129 152.753 510.103 268.875 69.398 
Total HP (CARR U) | active smokers 102 111.658 484.103 289.204 78.551 
(ANOVA, p = 0.180) (Kruskal-Wallis ANOVA, p = 0.077).
 
 
Statistical analysis of these results showed 
that there was no statistically significant difference in 
mean concentration of MDA and total HP in patients 
with CAD according to their smoking status. 
Concentration of MDA and the concentration 
of total HP were highest in patients with CAD who 
were active smokers and lowest in patients with CAD 
who had never smoked cigarettes. 
Then we measured the activity of superoxide 
dismutase (SOD), catalase (CAT) and glutathione 
peroxidase (GPX) in patients with CAD, according to 
the smoking status. The results are presented on 
Table 2.
 
Table 2: Activity of SOD, CAT and GPX in patients with CAD, 
according to the smoking status
 
  Pts Min Max Mean Standard deviation 
SOD (U/ml) | former smokers 69 10.477 571.631 128.620 114.651 
SOD (U/ml) | non-smokers
 127 12.118 560.085 139.121 122.408 
SOD (U/ml) | active smokers 101 10.477 525.138 124.602 99.219 
(ANOVA, p = 0.349) (Kruskal-Wallis ANOVA, p = 0.213)
 
CATALASE (U/L) | former smokers 68 0.313 136.242 62.517 37.084 
CATALASE (U/L) | non-smokers
 123 0.313 147.374 67.066 40.728 
CATALASE (U/L) | active smokers 94 0.430 133.137 63.889 36.780 
(ANOVA, p = 0.728) (Kruskall-Wallis ANOVA, p = 0.765)
 
GPx (U/ml)| former smokers 21 0.717 27.484 7.108 7.376 
GPx (U/ml)| non-smokers
 58 0.158 32.241 7.434 6.741 
GPx (U/ml)| active smokers 38 0.158 10.510 4.362 3.030 
(ANOVA, p = 0.042) (Kruskall-Wallis ANOVA, p = 0.038)
 
 
Statistical analysis of these results showed 
that there was a statistically significant difference in 
the mean activity only of GPX in patients with CAD 
according to their smoking status. 
In addition, the analysis showed that the 
activity of SOD was lowest among patients with CAD 
who were active smokers, and highest in patients with 
CAD who had never smoked cigarettes. 
 
Active smokers according of number of 
smoked cigarettes per day 
According to the number of smoked cigarettes 
per day, we examined if there is a difference in the 
concentration of MDA and total HP. The results are 
shown in Table 3.
 
Table 3: Concentration of MDA and total HP in patients with 
CAD who are active smokers according to the number of 
smoked cigarettes per day
 
  Pts Min Max Mean 
Standard 
deviation 
MDA (nmol/ml) | > 40 cigarettes 
per day 
3 21.301 55.982 35.606 8.208 
MDA (nmol/ml) | 1 - 20 cigarettes 
per day 
63 20.908 108.508 34.995 12.431 
MDA (nmol/ml) | 21 - 40 cigarettes 
per day 
36 28.108 43.964 34.212 8.535 
(ANOVA, p = 0.954) (Kruskal-Wallis ANOVA, p = 0.673)
 
Total HP (CARR U) | > 40 
cigarettes per day 
3 158.356 530.542 290.077 70.683 
Total HP (CARR U) | 1 - 20 
cigarettes per day 
63 126.000 499.013 272.709 69.808 
Total HP (CARR U) |21 - 40 
cigarettes per day 
36 219.138 347.661 284.062 64.272 
(ANOVA, p = 0.499) (Kruskal-Wallis ANOVA, p = 0.371)
 
 
Statistical analysis shows that there was no 
statistically significant difference of mean 
concentration of MDA and total HP in patients with 
CAD according to the number of smoked cigarettes. 
However, the concentrations of both 
parameters are highest in patients with CAD who 
smoke more than 40 cigarettes/day. 
Regarding the difference in the activity of 
antioxidant enzymes, SOD, CAT and GPX in patients 
with CAD who were active smokers, according to the 
number of smoked cigarettes per day, we received the 
following results which are shown in Table 4.
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Table 4: Activity of SOD, CAT and GPX (respectively) in 
patients with CAD who are active smokers according to the 
number of smoked cigarettes per day
 
  Pts Min Max Mean Standard deviation 
SOD (U/ml) | > 40 cigarettes per 
day 
3 36.952 96.256 68.102 29.765 
SOD (U/ml) | 1 - 20 cigarettes per 
day 
62 12.875 525.138 125.458 101.932 
SOD (U/ml) | 21 - 40 cigarettes 
per day 
36 10.477 397.393 124.984 98.553 
(ANOVA, p = 0.954) 
CATALASE (U/L) | > 40 cigarettes 
per day 
3 18.417 50.876 29.901 18.192 
CATALASE (U/L) | 1 - 20 
cigarettes per day 
58 0.313 147.374 70.462 42.368 
CATALASE (U/L) | 2 -40 
cigarettes per day 
33 11.562 137.062 64.478 38.019 
(ANOVA, p = 0.221) (Kruskal-Wallis ANOVA, p = 0.214)
 
GPx (U/ml)| > 40 cigarettes per 
day 
1 0.158 9.950 3.647 2.678 
GPx (U/ml)| 1 - 20 cigarettes per 
day 
22 1.370 10.510 5.412 3.393 
GPx (U/ml)| 21 - 40 cigarettes per 
day 
15 4.355 4.355 4.355 3.001 
(ANOVA, p = 0.225) (Kruskal-Wallis ANOVA, p = 0.170)
 
 
Statistical analysis shows that there was no 
statistically significant difference in activity of SOD, 
CAT and GPX in patients with CAD according to the 
number of smoked cigarettes. 
The activity of SOD, CAT and GPX is lowest 
in patients with CAD who smoke more than 40 
cigarettes/day and highest in patients with CAD who 
smoke 1-20 cigarettes/day. 
 
 
Discussion 
 
The results of our study clearly demonstrate 
that patients who smoke cigarettes have higher 
oxidative damage and reduced antioxidant status than 
those who never smoked. Our results showed that the 
concentrations of MDA and HP were higher in 
smokers versus non-smokers. 
In their study, Metta et al. [10] proved that 
there is an imbalance between oxidants and 
antioxidant enzymes in patients who had been 
admitted in the intensive coronary unit with a 
diagnosis of ischemic coronary heart disease. 
According to their smoking status, patients were 
divided to non-smokers and smokers. There was a 
statistically significant difference in the activity of GPX, 
SOD and CAT among smokers versus non-smokers. 
In addition, MDA levels in plasma were significantly 
increased in smokers compared to non-smokers. 
Also in studies of Lykkesfeldt et al. and Block 
et al. [11, 12] concentration of MDA in plasma and 
antioxidant profile were tested the in two groups of 
patients: smokers and non-smokers. It was proved 
that there is no significant difference in the antioxidant 
profile between the two groups, but there was a 
significant effect of smoking on the concentration of 
MDA in plasma. 
Jansen et al. [13] studied the influence of 
smoking on the levels of several biomarkers of 
oxidative stress, antioxidant status and redox status, 
including plasma hydroperoxides. Using different 
assays, they confirmed that smokers have elevated 
concentrations of oxidative stress biomarkers and 
compromised antioxidant status. 
Exposure to environmental tobacco smoke 
(ETS) is associated with increased risk of developing 
cardiovascular disease. A meta-analysis conducted in 
1999, published a total relative risk of 1.25 (95% CI = 
1.17, 1.32) and showed a dose-response relationship 
[14]. Even very short exposure to ETS can produce 
changes in platelet activation and endothelium-
dependent vasodilation [15]. Cigarette smoke contains 
high concentrations of toxic gases and tiny particles 
that are easily inhaled [16]. Therefore, exposure to 
ETS leads to a risk of cardiovascular events 
associated with active smoking. The study of Megson 
et al. [17] proved that patients with acute myocardial 
infarction (AMI) who were exposed to ETS and 
admitted to the intensive care unit had increased 
oxidative stress, as demonstrated by two independent 
plasma biomarkers (malondialdehyde and protein 
carbonyl). By this way they proved the role of ETS in 
the development of atherosclerosis and the 
occurrence of AMI. In conclusion, they put forward 
that exposure to cigarette smoke is associated with 
increased oxidative stress, by significantly higher 
concentrations of MDA in plasma. Exposure to 
cigarette smoke was associated with an increased risk 
of death from all causes, cardiovascular deaths, and 
fatal/nonfatal acute myocardial infarction within 30 
days of admission [18]. From here, it is plausible that 
oxidative stress may be involved in the mechanism by 
which exposure to cigarette smoke increases the risk 
of CAD. 
In our study, active smokers who smoke > 40 
cigarettes/day have higher oxidative stress than those 
who smoke 1-20 cigarettes/day or do not smoke, 
which means the number of cigarettes smoked is a 
significant risk factor for increased oxidative stress. 
Morbidity and mortality from CAD are very 
high in Turkey [19]. EUROASPIRE III study showed 
that 20% of subjects who were hospitalized with CAD 
in Turkey are less than 50 years of age. Turkey has 
the highest prevalence of early CAD of all populations. 
The main reasons are the low levels of cholesterol in 
high density lipoprotein (HDL-cholesterol) and high 
prevalence of smoking, which are more common in 
Turkey than in other countries [20]. A study of Aksoy 
et al. [21], where they examined indices of oxidative 
stress and severity of CAD in young patients who 
were hospitalized with AMI, proved that oxidative 
stress is an important factor for the severity of CAD in 
young smokers. Elevated levels of biomarkers of 
oxidative stress reflected the seriousness of the 
disease and vascular damage associated with 
cigarette smoking in the early onset CAD. 
The study of Bikkad et al. [22] confirmed the 
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view of increased lipid peroxidation and oxidative 
stress in smokers, expressed by increased 
concentration of MDA with a parallel reduction of 
antioxidant enzymes SOD and GPX. In this study, the 
level of SOD was significantly lower in smokers 
compared with non-smokers. The mechanism by 
which smoking causes low levels of blood SOD is 
unknown. Increased lipid peroxidation and antioxidant 
depletion in smokers may contribute for biomolecular 
vascular endothelial damage. The same study also 
reported a significant reduction in the level of GPX in 
smokers in comparison to the non-smokers. GPX 
seems to have a major role in the prevention of 
oxidative stress; it can also be an important anti-
atherogenic enzyme. This enzyme is responsible for 
the removal of hydrogen peroxide and organic 
hydroperoxides formed during cellular oxidative 
metabolism. 
In conclusion, smoking as a risk factor for 
CAD is closely linked to the increased oxidative 
stress. The number of cigarettes smoked per day 
plays an important role in increasing the level of 
oxidative damage and reducing the antioxidant 
defence, which results in increased oxidative stress. 
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